Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain

Hosung Jung, Sonia Bhangoo, Ghazal Banisadr, Caroline Freitag, Dongjun Ren, Fletcher White, Richard J. Miller

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

CCR2 chemokine receptor signaling has been implicated in the generation of diverse types of neuropathology, including neuropathic pain. For example, ccr2 knock-out mice are resistant to the establishment of neuropathic pain, and mice overexpressing its ligand, monocyte chemoattractant protein-1 (MCP1; also known as CCL2), show enhanced pain sensitivity. However, whether CCR2 receptor activation occurs in the central or peripheral nervous system in states of neuropathic pain has not been clear. We developed a novel method for visualizing CCR2 receptor activation in vivo by generating bitransgenic reporter mice in which the chemokine receptor CCR2 and its ligand MCP1 were labeled by the fluorescent proteins enhanced green fluorescent protein and monomeric red fluorescent protein-1, respectively. CCR2 receptor activation under conditions such as acute inflammation and experimental autoimmune encephalomyelitis could be faithfully visualized by using these mice. We examined the status of CCR2 receptor activation in a demyelination injury model of neuropathic pain and found that MCP1-induced CCR2 receptor activation mainly occurred in the peripheral nervous system, including the injured peripheral nerve and dorsal root ganglia. These data explain the rapid antinociceptive effects of peripherally administered CCR2 antagonists under these circumstances, suggesting that CCR2 antagonists may ameliorate pain by inhibiting CCR2 receptor activation in the periphery. The method developed here for visualizing CCR2 receptor activation in vivo may be extended to G-protein-coupled receptors (GPCRs) in general and will be valuable for studying intercellular GPCR-mediated communication in vivo.

Original languageEnglish (US)
Pages (from-to)8051-8062
Number of pages12
JournalJournal of Neuroscience
Volume29
Issue number25
DOIs
StatePublished - Jun 24 2009
Externally publishedYes

Fingerprint

CCR2 Receptors
Chemokine Receptors
Neuralgia
Transgenic Mice
Peripheral Nervous System
G-Protein-Coupled Receptors
Ligands
Pain
Autoimmune Experimental Encephalomyelitis
Chemokine CCL2
Spinal Ganglia
Demyelinating Diseases
Peripheral Nerves
Knockout Mice
Central Nervous System
Communication
Inflammation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. / Jung, Hosung; Bhangoo, Sonia; Banisadr, Ghazal; Freitag, Caroline; Ren, Dongjun; White, Fletcher; Miller, Richard J.

In: Journal of Neuroscience, Vol. 29, No. 25, 24.06.2009, p. 8051-8062.

Research output: Contribution to journalArticle

Jung, Hosung ; Bhangoo, Sonia ; Banisadr, Ghazal ; Freitag, Caroline ; Ren, Dongjun ; White, Fletcher ; Miller, Richard J. / Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. In: Journal of Neuroscience. 2009 ; Vol. 29, No. 25. pp. 8051-8062.
@article{4ccd2ddd5550415c9a95e3e4f3519ca7,
title = "Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain",
abstract = "CCR2 chemokine receptor signaling has been implicated in the generation of diverse types of neuropathology, including neuropathic pain. For example, ccr2 knock-out mice are resistant to the establishment of neuropathic pain, and mice overexpressing its ligand, monocyte chemoattractant protein-1 (MCP1; also known as CCL2), show enhanced pain sensitivity. However, whether CCR2 receptor activation occurs in the central or peripheral nervous system in states of neuropathic pain has not been clear. We developed a novel method for visualizing CCR2 receptor activation in vivo by generating bitransgenic reporter mice in which the chemokine receptor CCR2 and its ligand MCP1 were labeled by the fluorescent proteins enhanced green fluorescent protein and monomeric red fluorescent protein-1, respectively. CCR2 receptor activation under conditions such as acute inflammation and experimental autoimmune encephalomyelitis could be faithfully visualized by using these mice. We examined the status of CCR2 receptor activation in a demyelination injury model of neuropathic pain and found that MCP1-induced CCR2 receptor activation mainly occurred in the peripheral nervous system, including the injured peripheral nerve and dorsal root ganglia. These data explain the rapid antinociceptive effects of peripherally administered CCR2 antagonists under these circumstances, suggesting that CCR2 antagonists may ameliorate pain by inhibiting CCR2 receptor activation in the periphery. The method developed here for visualizing CCR2 receptor activation in vivo may be extended to G-protein-coupled receptors (GPCRs) in general and will be valuable for studying intercellular GPCR-mediated communication in vivo.",
author = "Hosung Jung and Sonia Bhangoo and Ghazal Banisadr and Caroline Freitag and Dongjun Ren and Fletcher White and Miller, {Richard J.}",
year = "2009",
month = "6",
day = "24",
doi = "10.1523/JNEUROSCI.0485-09.2009",
language = "English (US)",
volume = "29",
pages = "8051--8062",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "25",

}

TY - JOUR

T1 - Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain

AU - Jung, Hosung

AU - Bhangoo, Sonia

AU - Banisadr, Ghazal

AU - Freitag, Caroline

AU - Ren, Dongjun

AU - White, Fletcher

AU - Miller, Richard J.

PY - 2009/6/24

Y1 - 2009/6/24

N2 - CCR2 chemokine receptor signaling has been implicated in the generation of diverse types of neuropathology, including neuropathic pain. For example, ccr2 knock-out mice are resistant to the establishment of neuropathic pain, and mice overexpressing its ligand, monocyte chemoattractant protein-1 (MCP1; also known as CCL2), show enhanced pain sensitivity. However, whether CCR2 receptor activation occurs in the central or peripheral nervous system in states of neuropathic pain has not been clear. We developed a novel method for visualizing CCR2 receptor activation in vivo by generating bitransgenic reporter mice in which the chemokine receptor CCR2 and its ligand MCP1 were labeled by the fluorescent proteins enhanced green fluorescent protein and monomeric red fluorescent protein-1, respectively. CCR2 receptor activation under conditions such as acute inflammation and experimental autoimmune encephalomyelitis could be faithfully visualized by using these mice. We examined the status of CCR2 receptor activation in a demyelination injury model of neuropathic pain and found that MCP1-induced CCR2 receptor activation mainly occurred in the peripheral nervous system, including the injured peripheral nerve and dorsal root ganglia. These data explain the rapid antinociceptive effects of peripherally administered CCR2 antagonists under these circumstances, suggesting that CCR2 antagonists may ameliorate pain by inhibiting CCR2 receptor activation in the periphery. The method developed here for visualizing CCR2 receptor activation in vivo may be extended to G-protein-coupled receptors (GPCRs) in general and will be valuable for studying intercellular GPCR-mediated communication in vivo.

AB - CCR2 chemokine receptor signaling has been implicated in the generation of diverse types of neuropathology, including neuropathic pain. For example, ccr2 knock-out mice are resistant to the establishment of neuropathic pain, and mice overexpressing its ligand, monocyte chemoattractant protein-1 (MCP1; also known as CCL2), show enhanced pain sensitivity. However, whether CCR2 receptor activation occurs in the central or peripheral nervous system in states of neuropathic pain has not been clear. We developed a novel method for visualizing CCR2 receptor activation in vivo by generating bitransgenic reporter mice in which the chemokine receptor CCR2 and its ligand MCP1 were labeled by the fluorescent proteins enhanced green fluorescent protein and monomeric red fluorescent protein-1, respectively. CCR2 receptor activation under conditions such as acute inflammation and experimental autoimmune encephalomyelitis could be faithfully visualized by using these mice. We examined the status of CCR2 receptor activation in a demyelination injury model of neuropathic pain and found that MCP1-induced CCR2 receptor activation mainly occurred in the peripheral nervous system, including the injured peripheral nerve and dorsal root ganglia. These data explain the rapid antinociceptive effects of peripherally administered CCR2 antagonists under these circumstances, suggesting that CCR2 antagonists may ameliorate pain by inhibiting CCR2 receptor activation in the periphery. The method developed here for visualizing CCR2 receptor activation in vivo may be extended to G-protein-coupled receptors (GPCRs) in general and will be valuable for studying intercellular GPCR-mediated communication in vivo.

UR - http://www.scopus.com/inward/record.url?scp=67649360008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649360008&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.0485-09.2009

DO - 10.1523/JNEUROSCI.0485-09.2009

M3 - Article

C2 - 19553445

AN - SCOPUS:67649360008

VL - 29

SP - 8051

EP - 8062

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 25

ER -